Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 19716990)

1.

The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology.

Martin EI, Ressler KJ, Binder E, Nemeroff CB.

Psychiatr Clin North Am. 2009 Sep;32(3):549-75. doi: 10.1016/j.psc.2009.05.004. Review.

2.

The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology.

Martin EI, Ressler KJ, Binder E, Nemeroff CB.

Clin Lab Med. 2010 Dec;30(4):865-91. doi: 10.1016/j.cll.2010.07.006. Review.

PMID:
20832657
3.

Current status of brain imaging in anxiety disorders.

Damsa C, Kosel M, Moussally J.

Curr Opin Psychiatry. 2009 Jan;22(1):96-110. doi: 10.1097/YCO.0b013e328319bd10. Review.

PMID:
19122541
4.

Neuropeptide y: role in emotion and alcohol dependence.

Carvajal C, Dumont Y, Quirion R.

CNS Neurol Disord Drug Targets. 2006 Apr;5(2):181-95. Review.

PMID:
16611091
5.

Anxiety disorders: noradrenergic neurotransmission.

Neumeister A, Daher RJ, Charney DS.

Handb Exp Pharmacol. 2005;(169):205-23.

PMID:
16594260
6.

Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers.

Bourgeois JA, Seritan AL, Casillas EM, Hessl D, Schneider A, Yang Y, Kaur I, Cogswell JB, Nguyen DV, Hagerman RJ.

J Clin Psychiatry. 2011 Feb;72(2):175-82. doi: 10.4088/JCP.09m05407blu. Epub 2010 Aug 24.

7.

A systems neuroscience approach to the pathophysiology of pediatric mood and anxiety disorders.

Tseng WL, Leibenluft E, Brotman MA.

Curr Top Behav Neurosci. 2014;16:297-317. doi: 10.1007/7854_2013_252. Review.

PMID:
24281907
8.

Regional brain volume in depression and anxiety disorders.

van Tol MJ, van der Wee NJ, van den Heuvel OA, Nielen MM, Demenescu LR, Aleman A, Renken R, van Buchem MA, Zitman FG, Veltman DJ.

Arch Gen Psychiatry. 2010 Oct;67(10):1002-11. doi: 10.1001/archgenpsychiatry.2010.121.

PMID:
20921116
9.

Transgenic mice overexpressing the full-length neurotrophin receptor TrkC exhibit increased catecholaminergic neuron density in specific brain areas and increased anxiety-like behavior and panic reaction.

Dierssen M, Gratacòs M, Sahún I, Martín M, Gallego X, Amador-Arjona A, Martínez de Lagrán M, Murtra P, Martí E, Pujana MA, Ferrer I, Dalfó E, Martínez-Cué C, Flórez J, Torres-Peraza JF, Alberch J, Maldonado R, Fillat C, Estivill X.

Neurobiol Dis. 2006 Nov;24(2):403-18. Epub 2006 Sep 11.

PMID:
16963267
10.

The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies.

Heim C, Nemeroff CB.

Biol Psychiatry. 2001 Jun 15;49(12):1023-39. Review.

PMID:
11430844
11.

Anxiety disorders and schizophrenia.

Muller JE, Koen L, Soraya S, Emsley RA, Stein DJ.

Curr Psychiatry Rep. 2004 Aug;6(4):255-61. Review.

PMID:
15260940
12.

Brain imaging in anxiety disorders.

Bremner JD.

Expert Rev Neurother. 2004 Mar;4(2):275-84. Review.

PMID:
15853569
13.

The involvement of the vasopressin system in stress-related disorders.

Landgraf R.

CNS Neurol Disord Drug Targets. 2006 Apr;5(2):167-79. Review.

PMID:
16611090
14.

Cortico-limbic responses to masked affective faces across ptsd, panic disorder, and specific phobia.

Killgore WD, Britton JC, Schwab ZJ, Price LM, Weiner MR, Gold AL, Rosso IM, Simon NM, Pollack MH, Rauch SL.

Depress Anxiety. 2014 Feb;31(2):150-9. doi: 10.1002/da.22156. Epub 2013 Jul 16.

PMID:
23861215
15.

Structural magnetic resonance imaging in anxiety disorders: an update of research findings.

Ferrari MC, Busatto GF, McGuire PK, Crippa JA.

Rev Bras Psiquiatr. 2008 Sep;30(3):251-64. Review.

16.

The CANMAT task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders.

Schaffer A, McIntosh D, Goldstein BI, Rector NA, McIntyre RS, Beaulieu S, Swinson R, Yatham LN; Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force.

Ann Clin Psychiatry. 2012 Feb;24(1):6-22. Review.

PMID:
22303519
17.

Genetics of affective and anxiety disorders.

Leonardo ED, Hen R.

Annu Rev Psychol. 2006;57:117-37. Review.

PMID:
16318591
18.

Regulation of the glucocorticoid response to stress-related disorders by the Hsp90-binding immunophilin FKBP51.

Galigniana NM, Ballmer LT, Toneatto J, Erlejman AG, Lagadari M, Galigniana MD.

J Neurochem. 2012 Jul;122(1):4-18. doi: 10.1111/j.1471-4159.2012.07775.x. Epub 2012 May 21. Review.

PMID:
22548329
19.

Pharmacotherapy of comorbid mood, anxiety, and substance use disorders.

Brady KT, Verduin ML.

Subst Use Misuse. 2005;40(13-14):2021-41, 2043-8. Review.

PMID:
16282091
20.

Risk and resilience: genetic and environmental influences on development of the stress response.

Gillespie CF, Phifer J, Bradley B, Ressler KJ.

Depress Anxiety. 2009;26(11):984-92. doi: 10.1002/da.20605. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk